Mouse Anti-IL13 Recombinant Antibody (PVM13-1) (CBMAB-I0992-YY)

Name: Mouse Anti-IL13 Recombinant Antibody (PVM13-1)
SKU: CBMAB-I0992-YY
Rating: 5 (1 reviews)

See all IL13 antibodies

Compare Online Inquiry

Datasheet

SDS

Request for COA

Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Host Animal

Mouse

Clone

PVM13-1

Application

ELISA, FC, FuncS, Neut

Specificity

Human

Antibody Isotype

IgG1

Clonality

Monoclonal

Application Notes

The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format

Liquid

Buffer

PBS, pH 7.2

Preservative

0.09% sodium azide

Concentration

0.5 mg/mL

Storage

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

More Infomation

Target

Full Name

Interleukin 13

Introduction

This gene encodes an immunoregulatory cytokine produced primarily by activated Th2 cells. This cytokine is involved in several stages of B-cell maturation and differentiation. It up-regulates CD23 and MHC class II expression, and promotes IgE isotype switching of B cells. This cytokine down-regulates macrophage activity, thereby inhibits the production of pro-inflammatory cytokines and chemokines. This cytokine is found to be critical to the pathogenesis of allergen-induced asthma but operates through mechanisms independent of IgE and eosinophils. This gene, IL3, IL5, IL4, and CSF2 form a cytokine gene cluster on chromosome 5q, with this gene particularly close to IL4.

Entrez Gene ID

3596

UniProt ID

P35225

Alternative Names

Interleukin 13

Function

Cytokine (PubMed:8096327, PubMed:8097324).

Inhibits inflammatory cytokine production (PubMed:8096327).

Synergizes with IL2 in regulating interferon-gamma synthesis (PubMed:8096327).

May be critical in regulating inflammatory and immune responses (PubMed:8096327, PubMed:8097324).

Positively regulates IL31RA expression in macrophages (By similarity).

Biological Process

Cellular response to cytokine stimulus Source: Ensembl
Cellular response to mechanical stimulus Source: Ensembl
Immune response Source: InterPro
Inflammatory response Source: ProtInc
Macrophage activation Source: ARUK-UCL
Microglial cell activation Source: Ensembl
Negative regulation of complement-dependent cytotoxicity Source: AgBase
Negative regulation of endothelial cell apoptotic process Source: AgBase
Negative regulation of inflammatory response Source: ARUK-UCL
Negative regulation of lung ciliated cell differentiation Source: BHF-UCL
Negative regulation of NAD(P)H oxidase activity Source: Ensembl
Negative regulation of neuron death Source: Ensembl
Negative regulation of transforming growth factor beta production Source: Ensembl
Positive regulation of B cell proliferation Source: Ensembl
Positive regulation of cold-induced thermogenesis Source: YuBioLab
Positive regulation of connective tissue growth factor production Source: Ensembl
Positive regulation of gene expression Source: ARUK-UCL
Positive regulation of immunoglobulin production Source: Ensembl
Positive regulation of interleukin-10 production Source: ARUK-UCL
Positive regulation of lung goblet cell differentiation Source: BHF-UCL
Positive regulation of macrophage activation Source: Ensembl
Positive regulation of mast cell degranulation Source: Ensembl
Positive regulation of pancreatic stellate cell proliferation Source: Ensembl
Positive regulation of protein secretion Source: Ensembl
Positive regulation of release of sequestered calcium ion into cytosol Source: Ensembl
Positive regulation of smooth muscle cell proliferation Source: Ensembl
Positive regulation of tyrosine phosphorylation of STAT protein Source: Ensembl
Regulation of proton transport Source: Ensembl
Response to ethanol Source: Ensembl
Response to lipopolysaccharide Source: Ensembl
Response to nicotine Source: Ensembl

Cellular Location

Secreted

Involvement in disease

Allergic rhinitis (ALRH):
A common disease with complex inheritance characterized by mucosal inflammation caused by allergen exposure.

Jia, F., Zhao, Q., Shi, P., Liu, H., & Zhang, F. (2022). Dupilumab: Advances in the off‐label usage of IL4/IL13 antagonist in dermatoses. Dermatologic Therapy, 35(12), e15924.

Stern, L. A., Gholamin, S., Moraga, I., Yang, X., Saravanakumar, S., Cohen, J. R., ... & Brown, C. E. (2022). Engineered IL13 variants direct specificity of IL13Rα2-targeted CAR T cell therapy. Proceedings of the National Academy of Sciences, 119(33), e2112006119.

Noto, C. N., Hoft, S. G., Bockerstett, K. A., Jackson, N. M., Ford, E. L., Vest, L. S., & DiPaolo, R. J. (2022). IL13 Acts directly on gastric epithelial cells to promote Metaplasia Development during Chronic Gastritis. Cellular and Molecular Gastroenterology and Hepatology, 13(2), 623-642.

Campanati, A., Orciani, M., Marani, A., Di Vincenzo, M., Magi, S., Gregoriou, S., ... & Offidani, A. (2022). Mesenchymal stem cells profile in adult atopic dermatitis and effect of IL4-IL13 inflammatory pathway inhibition In vivo: Prospective case-control study. journal of clinical medicine, 11(16), 4759.

Ramonell, R. P., & Iftikhar, I. H. (2020). Effect of anti-IL5, anti-IL5R, anti-IL13 therapy on asthma exacerbations: a network meta-analysis. Lung, 198, 95-103.

Hirano, I., Collins, M. H., Assouline-Dayan, Y., Evans, L., Gupta, S., Schoepfer, A. M., ... & HEROES Study Group. (2019). RPC4046, a monoclonal antibody against IL13, reduces histologic and endoscopic activity in patients with eosinophilic esophagitis. Gastroenterology, 156(3), 592-603.

Heiss, J. D., Jamshidi, A., Shah, S., Martin, S., Wolters, P. L., Argersinger, D. P., ... & Lonser, R. R. (2018). Phase I trial of convection-enhanced delivery of IL13-Pseudomonas toxin in children with diffuse intrinsic pontine glioma. Journal of Neurosurgery: Pediatrics, 23(3), 333-342.

Rahal, O. M., Wolfe, A. R., Mandal, P. K., Larson, R., Tin, S., Jimenez, C., ... & Woodward, W. A. (2018). Blocking interleukin (IL) 4-and IL13-mediated phosphorylation of STAT6 (Tyr641) decreases M2 polarization of macrophages and protects against macrophage-mediated radioresistance of inflammatory breast cancer. International Journal of Radiation Oncology* Biology* Physics, 100(4), 1034-1043.

Hamzei Taj, S., Le Blon, D., Hoornaert, C., Daans, J., Quarta, A., Praet, J., ... & Hoehn, M. (2018). Targeted intracerebral delivery of the anti-inflammatory cytokine IL13 promotes alternative activation of both microglia and macrophages after stroke. Journal of neuroinflammation, 15, 1-17.

Venkataramani, S., Low, S., Weigle, B., Dutcher, D., Jerath, K., Menzenski, M., ... & Erb, K. J. (2018). Design and characterization of Zweimab and Doppelmab, high affinity dual antagonistic anti-TSLP/IL13 bispecific antibodies. Biochemical and biophysical research communications, 504(1), 19-24.

Ask a question We look forward to hearing from you.

0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Have you used Mouse Anti-IL13 Recombinant Antibody (PVM13-1)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

$30 eGift Card
Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols

Antibody Pairs

IL13 Matched Antibody Pair (613) (CAT#: APMAB-613LY)

IL13 Matched Antibody Pair (614) (CAT#: APMAB-614LY)

IL13 Matched Antibody Pair (615) (CAT#: APMAB-615LY)

IL13 Matched Antibody Pair (616) (CAT#: APMAB-616LY)

IL13 Matched Antibody Pair (617) (CAT#: APMAB-617LY)

Related Products

Mouse Anti-IL13 Recombinant Antibody (CBYC-A984) (CAT#: CBMAB-A4481-YC)

Mouse Anti-IL13 Recombinant Antibody (A130D 12G5 1E4) (CAT#: CBMAB-I1851-YY)

Mouse Anti-IL13 Recombinant Antibody (CBYY-I0782) (CAT#: CBMAB-I1730-YY)

IL13 Matched Antibody Pair (614) (CAT#: APMAB-614LY)

Rat Anti-IL13 Recombinant Antibody (CBYY-I0657) (CAT#: CBMAB-I1470-YY)

Mouse Anti-IL13 Recombinant Antibody (2E12) (CAT#: CBMAB-A4332-LY)

Rabbit Anti-IL13 Recombinant Antibody (CBYY-I0569) (CAT#: CBMAB-I1256-YY)

Rat Anti-IL13 Recombinant Antibody (CBYY-I0596) (CAT#: CBMAB-I1299-YY)

Rat Anti-IL13 Recombinant Antibody (JES10-5A2) (CAT#: CBMAB-I0396-YY)

Mouse Anti-IL13 Recombinant Antibody (5E2) (CAT#: CBMAB-A4329-LY)

Isotype control

For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Request bulk or custom quote Second antibody and isotype control

Contact us

Tel: (USA)
(UK)
Fax:

Global Locations

Email:

Online Inquiry